Y Intercept (Hong Kong) LTD Pds Biotechnology Corp Transaction History
Y Intercept (Hong Kong) LTD
- $1.78 Billion
- Q2 2024
A detailed history of Y Intercept (Hong Kong) LTD transactions in Pds Biotechnology Corp stock. As of the latest transaction made, Y Intercept (Hong Kong) LTD holds 45,883 shares of PDSB stock, worth $151,413. This represents 0.01% of its overall portfolio holdings.
Number of Shares
45,883Holding current value
$151,413% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding PDSB
# of Institutions
77Shares Held
5.49MCall Options Held
155KPut Options Held
61.7K-
Vanguard Group Inc Valley Forge, PA1.41MShares$4.65 Million0.0% of portfolio
-
Black Rock Inc. New York, NY487KShares$1.61 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny381KShares$1.26 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA378KShares$1.25 Million0.0% of portfolio
-
Inspirion Wealth Advisors, LLC344KShares$1.14 Million0.18% of portfolio
About PDS Biotechnology Corp
- Ticker PDSB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 28,458,700
- Market Cap $93.9M
- Description
- PDS Biotechnology Corporation, a clinical-stage biopharmaceutical company, focuses on developing multifunctional cancer immunotherapies. Its lead product candidate is PDS0101 (HPV16), which is in Phase II clinical trial provides a first line treatment for the recurrent/metastatic head and neck cancer, human papillomavirus associated malignancies...